Vitality Biopharma Inc (OTCMKTS:VBIO) is in two highly volatile industries- Cannabis and Biopharma. Cannabis related biopharma is a buzzword that has become an important industry term the investing world realizes will deliver revenues that have nothing to do with retail pot sales.
Vitality Biopharma Inc (OTCMKTS:VBIO) is in the business of biopharma, and they released one of the first clinical reports detailing the ability of cannabinoid therapy to induce remission in a pediatric inflammatory bowel disease patients as solutions for Crohn’s disease and colitis where patients seek healthier solutions. VBIO published a study on this subject and it has given some lift to the stock recently.
The report is a case study titled, “Induction of Remission in Drug-Resistant Pediatric Inflammatory Bowel Disease with Cannabinoid Therapy,” and describes a 13-year-old boy with drug-resistant Crohn’s disease and colitis who achieved clinical remission after oral administration of cannabinoids. Independently from the Company, the patient received treatment with medical